Catalyst Wire Dossier Catalyst Wire Dossier

Ranquilon

· Valenta Pharm JSC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ranquilon, covering 2023-07-27 to 2025-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders [Phase 4]

See pricing